EUVIMEDEUVIMED entdecken
EditorialOpen Access

Artificial intelligence–guided nanoparticle design for advanced targeted drug delivery

Morteza Eskandani iD

BioImpacts · 01.12.2025 · 15 · 33066

DOI: 10.34172/bi.33066 ↗

Kurz gefasst

Editorial in der Zeitschrift BioImpacts, online erschienen am 01.12.2025. Verfasst von Morteza Eskandani. Beteiligte Einrichtung: Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This editorial aimed to explore the critical role of artificial intelligence (AI) in accurately predicting the structural design of nanoparticles (NPs) during targeted therapy of diseases. Based on experience, it is always surprising that perfect control of NP properties—including size, zeta potential, type, and surface modifications—using smart tools, will be more critical for optimal outcomes than trial and error. It is envisioned that the AI will change the game by predicting NPs' behavior, optimizing formulations, and speeding up clinical trials via the use of supervised learning, deep neural networks, graph neural networks, and generative models. In this context, various AI have led to an increase in drug loading efficiency and mRNA medication delivery. To achieve personalized therapy using NPs, however, issues including data quality, model interpretability, ethical frameworks, and multidisciplinary cooperation should be resolved. To enhance human knowledge and facilitate safer and more precise advancements in healthcare, this editorial urges the proper integration of AI in pharmaceutical/medical nanotechnology.

Schlagwörter

Stichwörter der Autor:innen

Artificial intelligenceDesignDrug delivery systemsEthical challengesHumanNanoparticlePharmaceutical nanotechnologySurface modificationZeta potential

Autor:innen und Institutionen

  • Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

ORCID-Profile: Morteza Eskandani

Zitieren

APA

Eskandani, M. (2025). Artificial intelligence–guided nanoparticle design for advanced targeted drug delivery. BioImpacts, 15, 33066. https://doi.org/10.34172/bi.33066

Vancouver

Eskandani M. Artificial intelligence–guided nanoparticle design for advanced targeted drug delivery. BioImpacts. 2025;15:33066. doi:10.34172/bi.33066

BibTeX
@article{Eskandani2025,
  author = {Eskandani, Morteza},
  title = {Artificial intelligence–guided nanoparticle design for advanced targeted drug delivery},
  journal = {BioImpacts},
  year = {2025},
  volume = {15},
  pages = {33066},
  doi = {10.34172/bi.33066}
}
Kostenlos starten →